You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 3, 2024

FAMOTIDINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Famotidine, and what generic alternatives are available?

Famotidine is a drug marketed by Ajanta Pharma Ltd, Akorn, Alkem Labs Ltd, Amneals Pharms, Annora Pharma, Carnegie, Lupin Ltd, Micro Labs, Navinta Llc, Novel Labs Inc, Novitium Pharma, Unichem, Upsher Smith Labs, Apotex Inc, Apothecon, Fresenius Kabi Usa, Hikma, Hospira, Mylan Labs Ltd, Sagent, Zydus Pharms, Perrigo, Actavis Elizabeth, Alembic Pharms Ltd, Apotex, Ascent Pharms Inc, Aurobindo Pharma, Aurobindo Pharma Ltd, Carlsbad, Chartwell Rx, Contract Pharmacal, Dr Reddys Labs Ltd, Glenmark Pharms Inc, Graviti Pharms, Ivax Sub Teva Pharms, Mankind Pharma, Marksans Pharma, MSN, Mylan Pharms Inc, Natco Pharma, P And L, Perrigo R And D, Rising, Sandoz, Sun Pharm Inds Ltd, Sun Pharm Industries, Teva, Vkt Pharma, Watson Labs, Torrent, Epic Pharma Llc, Abbvie, Baxter Hlthcare, and Endo Operations. and is included in eighty-six NDAs.

The generic ingredient in FAMOTIDINE is calcium carbonate; famotidine; magnesium hydroxide. There are two hundred and eighty-two drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the calcium carbonate; famotidine; magnesium hydroxide profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FAMOTIDINE?
  • What are the global sales for FAMOTIDINE?
  • What is Average Wholesale Price for FAMOTIDINE?
Drug patent expirations by year for FAMOTIDINE
Drug Prices for FAMOTIDINE

See drug prices for FAMOTIDINE

Drug Sales Revenue Trends for FAMOTIDINE

See drug sales revenues for FAMOTIDINE

Recent Clinical Trials for FAMOTIDINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of MiamiPhase 3
CelgenePhase 1
Emory UniversityPhase 3

See all FAMOTIDINE clinical trials

Pharmacology for FAMOTIDINE
Medical Subject Heading (MeSH) Categories for FAMOTIDINE

US Patents and Regulatory Information for FAMOTIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Msn FAMOTIDINE famotidine TABLET;ORAL 217400-001 Aug 6, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs FAMOTIDINE famotidine TABLET;ORAL 075062-002 Apr 16, 2001 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apotex FAMOTIDINE famotidine TABLET;ORAL 075611-002 Jul 23, 2001 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.